CC
HUM icon

Cannell & Co’s Humana HUM Stock Holding History

Cannell & Co’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.16M Sell
4,727
-98,031
-95% -$48.3M 0.07% 131
2023
Q3 		$50M Buy
102,758
+26,284
+34% +$12.4M 1.71% 14
2023
Q2 		$34.2M Buy
76,474
+66,326
+654% +$33.4M 1.14% 23
2023
Q1 		$4.93M Buy
10,148
+3,320
+49% +$1.64M 0.18% 108
2022
Q4 		$3.5M Sell
6,828
-15,797
-70% -$8.3M 0.13% 111
2022
Q3 		$11M Buy
22,625
+545
+2% +$265K 0.42% 71
2022
Q2 		$10.3M Sell
22,080
-17,107
-44% -$7.61M 0.37% 80
2022
Q1 		$17.1M Sell
39,187
-78,579
-67% -$32.9M 0.51% 63
2021
Q4 		$54.6M Buy
117,766
+57,683
+96% +$25.5M 1.55% 14
2021
Q3 		$23.4M Buy
+60,083
New +$25.5M 0.71% 47

Other funds holding HUM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cannell & Co's HUM Position: Q4 2023 in Review

Cannell & Co reduced its Humana (HUM) stake by 95% in Q4 2023, selling an estimated $48.3M and leaving 4,727 shares worth $2.16M. The position accounts for 0.07% of the portfolio, ranked #131.

Cannell & Co first reported a position in HUM in Q3 2021 and has held it in 10 quarters since. The position peaked at $54.6M in Q4 2021. 1,153 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

  • Cannell & Co held 4,727 shares of Humana worth $2.16M as of Q4 2023.
  • Cannell & Co sold 98,031 Humana shares in Q4 2023, an estimated $48.3M.
  • Humana made up 0.07% of Cannell & Co's portfolio in Q4 2023, its #131 holding.
  • Cannell & Co first reported a position in Humana in Q3 2021 and has held it in 10 quarters since.
  • Cannell & Co's Humana position peaked at $54.6M in Q4 2021.
  • 1,153 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.